Home > Qtrly Results > ALKEM LABORATORIES

ALKEM LABORATORIES
Quarterly Results Analysis [Sep2024]

ALKEM LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for ALKEM LABORATORIES
Please provide your vote to see the results

ALKEM LABORATORIES Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹3,415 Cr ₹3,032 Cr ₹2,936 Cr ₹3,324 Cr ₹3,440 Cr ₹2,968 Cr ₹2,903 Cr ₹3,041 Cr
Expenses ₹2,662 Cr ₹2,423 Cr ₹2,534 Cr ₹2,616 Cr ₹2,693 Cr ₹2,579 Cr ₹2,549 Cr ₹2,442 Cr
Operating Income ₹753 Cr ₹609 Cr ₹402 Cr ₹708 Cr ₹747 Cr ₹389 Cr ₹353 Cr ₹599 Cr
Other Income ₹134 Cr ₹120 Cr ₹88 Cr ₹94 Cr ₹63 Cr ₹66 Cr ₹69 Cr ₹45 Cr
Interest ₹28 Cr ₹29 Cr ₹27 Cr ₹25 Cr ₹30 Cr ₹30 Cr ₹29 Cr ₹27 Cr
Depreciation ₹79 Cr ₹80 Cr ₹83 Cr ₹70 Cr ₹74 Cr ₹72 Cr ₹78 Cr ₹78 Cr
Profit Before Tax ₹780 Cr ₹619 Cr ₹367 Cr ₹655 Cr ₹648 Cr ₹353 Cr ₹212 Cr ₹539 Cr
Profit After Tax ₹702 Cr ₹550 Cr ₹304 Cr ₹604 Cr ₹615 Cr ₹288 Cr ₹68 Cr ₹460 Cr
EPS ₹57.60 ₹45.60 ₹24.56 ₹49.77 ₹51.90 ₹23.98 ₹5.94 ₹38.04
Industry Peers & Returns1W1M1Y
ALKEM LABORATORIES 0.4% -4.3% 2.9%
SUN PHARMACEUTICAL INDUSTRIES 2.3% -0.8% 32.7%
CIPLA 0.3% -2% 10%
DR REDDYS LABORATORIES -1.8% 2.7% 12.7%
ZYDUS LIFESCIENCES 2% 1.5% 38%
DIVIS LABORATORIES 3.2% 1.1% 51.5%
MANKIND PHARMA 0.4% -7.3% 16.5%
TORRENT PHARMACEUTICALS -1.9% -6% 28.4%
LUPIN -2% 0.6% 48.6%

ALKEM LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

12.63 %

Y-o-Y

-0.74 %

Quarters Revenues % Change
Sep2024 ₹3,415 Cr
12.63
Jun2024 ₹3,032 Cr
3.27
Mar2024 ₹2,936 Cr
-11.67
Dec2023 ₹3,324 Cr
-3.38
Sep2023 ₹3,440 Cr
15.92
Jun2023 ₹2,968 Cr
2.24
Mar2023 ₹2,903 Cr
-4.55
Dec2022 ₹3,041 Cr -

ALKEM LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

23.69 %

Y-o-Y

0.82 %

Quarters Operating Profit % Change
Sep2024 ₹753 Cr
23.69
Jun2024 ₹609 Cr
51.41
Mar2024 ₹402 Cr
-43.19
Dec2023 ₹708 Cr
-5.24
Sep2023 ₹747 Cr
91.87
Jun2023 ₹389 Cr
10.17
Mar2023 ₹353 Cr
-41.03
Dec2022 ₹599 Cr -
Operating Margins
Q-o-Q

9.81 %

Y-o-Y

1.57 %

Quarters Operating Margin% % Change
Sep2024 22.05%
9.81
Jun2024 20.08%
46.68
Mar2024 13.69%
-35.70
Dec2023 21.29%
-1.93
Sep2023 21.71%
65.60
Jun2023 13.11%
7.72
Mar2023 12.17%
-38.22
Dec2022 19.7% -

ALKEM LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

27.57 %

Y-o-Y

14.16 %

Quarters Profit After Tax % Change
Sep2024 ₹702 Cr
27.57
Jun2024 ₹550 Cr
80.71
Mar2024 ₹304 Cr
-49.61
Dec2023 ₹604 Cr
-1.73
Sep2023 ₹615 Cr
113.64
Jun2023 ₹288 Cr
325.25
Mar2023 ₹68 Cr
-85.29
Dec2022 ₹460 Cr -
PAT Margins
Q-o-Q

13.28 %

Y-o-Y

15.05 %

Quarters PAT Margin(%) % Change
Sep2024 20.56 %
13.28
Jun2024 18.15 %
75.02
Mar2024 10.37 %
-42.96
Dec2023 18.18 %
1.73
Sep2023 17.87 %
84.23
Jun2023 9.7 %
316.31
Mar2023 2.33 %
-84.60
Dec2022 15.13 % -

ALKEM LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

26.32 %

Y-o-Y

10.98 %

Quarters EPS % Change
Sep2024 ₹57.6
26.32
Jun2024 ₹45.6
85.67
Mar2024 ₹24.56
-50.65
Dec2023 ₹49.77
-4.10
Sep2023 ₹51.9
116.43
Jun2023 ₹23.98
303.70
Mar2023 ₹5.94
-84.38
Dec2022 ₹38.04 -

You may also like the below Video Courses